Global CBD markets are under pressure after the European Commission (EC) asserted that CBD extracts from hemp flowers aren’t valid for approval under the Novel Foods policy. A spokesperson for the EC said primary concern lies with “CBD extracted from the flowering and fruiting tops of the hemp plant (Cannabis sativa)”. The European Commission has “informed the applicants of its preliminary views and invited them to provide comments”, the spokesperson added. This includes 50 applicants from a number of countries, including the US.
Czech based CBDepot submitted their application for synthetic CBD to the European Food Safety Authority (EFSA) in November of last year. On March 31, CBDepot’s application for registering synthesized trans-CBD as a ‘Novel Food’ substance appeared as EC Mandate# M-2018-0021 on EFSA’s Register of Questions portal:
…
02.21.2025
US animal fats and oils markets finish week strong; broader uncertainty persists
The US animal fats and oils markets ended Friday February 21 on a relatively quiet note, though broader market developments throughout the week have added ongoing uncertainty to the...
02.21.2025
Sausage casings bulletin, February 21, 2025
Runner market commentary
Table 1
02.21.2025
US weekly net soybean meal exports, sales retreat again
In the week to February 13, US net soybean meal and soybean cake sales and exports continued to decline but were above most analysts' estimates, data released by the...